Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTION, ORALGeneric

PHOSPHOTOPE

SODIUM PHOSPHATE P-32

Standard Dose
1-8mCi/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PHOSPHOTOPE is listed in Drugs@FDA under application 010927 (NDA).

Marketing status: Discontinued Active ingredient SODIUM PHOSPHATE P-32 Form and strength SOLUTION;INJECTION, ORAL - 1-8mCi/VIAL Sponsor BRACCO Submission history Latest submission status date: 1978-10-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHOSPHOTOPE is listed in Drugs@FDA under application 010927 (NDA). Marketing status: Discontinued Active ingredient SODIUM PHOSPHATE P-32 Form and strength SOLUTION;INJECTION, ORAL - 1-8mCi/VIAL Sponsor BRACCO Submission history Latest submission status date: 1978-10-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PHOSPHOTOPE (SODIUM PHOSPHATE P-32) | Drug Monograph | MedicHelpline